Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity

Nature

Volumn 364, Issue 6439, 1993, Pages 725-729

  Cox, Gregory A ^a   Cole, Neil M ^a   Matsumura, Kiichiro ^b   Phelps, Stephanie F ^a   Hauschka, Stephen D ^c   Campbell, Kevin P ^a   Faulkner, John A ^a   Chamberlain, Jeffrey S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMAL; CREATINE KINASE; DISEASE MODELS, ANIMAL; DYSTROPHIN; FEASIBILITY STUDIES; FEMALE; GENE AMPLIFICATION; GENE THERAPY; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUSCLES; MUSCULAR DYSTROPHIES; MYOCARDIUM; SARCOLEMMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA;

EID: 0027186053     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/364725a0     Document Type: Article

References (27)

1. Hoffman, E. P., Brown, R. H. Jr & Kunkel, L. M. Cell 51, 919–928 (1987).
2. Ahn, A. H. & Kunkel, L. M. Nature Genet 3, 283–291 (1993).
3. Sicinski, P. et al. Science 244, 1578–1580 (1989).
4. Cox, G. A., Phelps, S. F., Chapman, V. M. & Chamberlain, J. S. Nature Genet. 4, 87-93, (1993).
5. Partridge, T. Neuropathol. appl. Neurobiot. 17, 353–363 (1991).
6. Stedman, H. H. et al. Nature 352, 536–539 (1991).
7. Lee, C. C., Pearlman, J. A., Chamberlain, J. S. & Caskey, C. T. Nature 349, 334–336 (1991).
8. Jaynes, J. B., Chamberlain, J. S., Buskin, J. N., Johnson, J. E. & Hauschka, S. D. Molec. cell Biol. 6, 2855–2864 (1986).
9. Johnson, J. E., Wold, B. J. & Hauschka, S. D. Molec. cell. Biol. 9, 3393–3399 (1989).
10. Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G. & Campbell, K. P. Nature 345, 315–319 (1990).
11. Ervasti, J. M. & Campbell, K. P. Cell 66, 1121–1131 (1991).
12. Ibragbimov-Beskrovnaya, O. et al. Nature 355, 696–702 (1992).
13. Ohlendieck, K. & Campbell, K. P. J. Cell Biol. 115, 1685–1694 (1991).
14. Ohlendieck, K. et al. Neurology 43, 795–800 (1993).
15. Matsumura, K. et al. Nature 359, 320–322 (1992).
16. Matsumura, K., Ervasti, J. M., Ohlendieck, K., Kahl, S. & Campbell, K. P. Nature 360, 588–591 (1992).
17. Chapman, V. M., Miller, D. M., Armstrong, D. & Caskey, C. T. Proc. natn. Acad. Sci. U.SA. 86, 1292–1296 (1989).
18. Watkins, S. C., Hoffman, E. P., Slayter, H. S. & Kunkel, L. M. Muscle Nerve 12, 861–868 (1989).
19. Wells, D. J. et al. Hum. molec. Genet. 1, 35–40 (1992).
20. Ragot, T. et al. Nature 361, 647–650 (1993).
21. Emery, A. E. H. Duchenne Muscular Dystrophy (Oxford Monog. Med. Genet. No. 15, Oxford Medical, 1987).
22. Hogan, B„ Constantini, F. & Lacey, E. Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory Press, New York, 1986).
23. Chamberlain, J. S., Phelps, S. F., Cox, G. A., Maichele, A. J. & Greenwood, A. D. in Molecular and Cell Biology of Muscular Dystrophy (ed. Partridge, T.) 167-189 (Chapman & Hall, London, 1993).
24. Ohlendieck, K. et al. Neuron 7, 499–508 (1991).
25. Ervasti, J. M., Kahl, S. D. & Campbell, K. P. J. biol. Chem. 266, 9161–9165 (1991).
26. Faulkner, J. A., Zerba, E. & Brooks, S. V. Am. J. Physiol. 259, 259–265 (1990).
27. Brooks, S. V. & Faulkner, J. A. J. Physiol. 436, 701–710 (1991).